VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $172.08)
- $172.08 P/E (TTM): 21.97X Cap: $360M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $149.95)
- $149.95 P/E (TTM): 18.7X Cap: $6.16B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $26.83)
- $26.83 Cap: $10.43B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $172.08)
- $172.08 P/E (TTM): 21.97X Cap: $360M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $149.95)
- $149.95 P/E (TTM): 18.7X Cap: $6.16B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $73.07)
- $73.07 Cap: $6.64B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $172.08)
- $172.08 P/E (TTM): 21.97X Cap: $360M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $564.63)
- $564.63 P/E (TTM): 14.21X Cap: $59.84B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $190.72)
- $190.72 P/E (TTM): 20.4X Cap: $459.31B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $833.49)
- $833.49 P/E (TTM): 54.48X Cap: $788.86B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $85.99)
- $85.99 P/E (TTM): 13.26X Cap: $214.78B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $24.78)
- $24.78 P/E (TTM): 13.18X Cap: $140.88B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $524.80)
- $524.80 P/E (TTM): 30.35X Cap: $198.17B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $56.93)
- $56.93 P/E (TTM): 16.0X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $149.95)
- $149.95 P/E (TTM): 18.7X Cap: $6.16B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $26.83)
- $26.83 Cap: $10.43B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $172.08)
- $172.08 P/E (TTM): 21.97X Cap: $360M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $74.04)
- $74.04 P/E (TTM): 19.22X Cap: $596M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023